APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antithyroid Preparations

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antithyroid Preparations Market Analysis and Forecast 2026-2032

27 December 2025214 pages

Choose your research edition.

Industry ResearchAntithyroid Preparations Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithyroid Preparations Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Antithyroid Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithyroid Preparations Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithyroid Preparations Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Antithyroid Preparations market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antithyroid Preparations is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antithyroid Preparations is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antithyroid Preparations is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antithyroid Preparations is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antithyroid Preparations include Taishan Xinning Pharmaceutical Co., Ltd., Shenzhen Zhonglian Pharmaceutical Co., Ltd., Shanghai Xinyi Tianping Pharmaceutical Co., Ltd., Shanghai Zhaohui Pharmaceutical Co., Ltd., Sanmenxia Sinovi Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Liaoning Kangbo Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd. and Jinghua Pharmaceutical Group Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antithyroid Preparations, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antithyroid Preparations, also provides the sales of main regions and countries. Of the upcoming market potential for Antithyroid Preparations, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antithyroid Preparations sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antithyroid Preparations market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antithyroid Preparations sales, projected growth trends, production technology, application and end-user industry.

Antithyroid Preparations Segment by Company

Taishan Xinning Pharmaceutical Co., Ltd.

Shenzhen Zhonglian Pharmaceutical Co., Ltd.

Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.

Shanghai Zhaohui Pharmaceutical Co., Ltd.

Sanmenxia Sinovi Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Liaoning Kangbo Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jinghua Pharmaceutical Group Co., Ltd.

Jinyao Pharmaceutical Co., Ltd.

Hunan Xiangzhong Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Guizhou Shengjitang Pharmaceutical Co., Ltd.

Guangzhou Kanghe Pharmaceutical Co., Ltd.

Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.

Guangdong South China Pharmaceutical Group Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Beijing Yongkang Pharmaceutical Co., Ltd.

Beijing Jialin Pharmaceutical Co., Ltd.

Beijing Beiwei Pharmaceutical Co., Ltd.

Upsher-Smith Laboratories, LLC

Teva

Pfizer

Avet Pharmaceuticals Inc.

Antithyroid Preparations Segment by Type

Propylthiouracil

Methimazole

Antithyroid Preparations Segment by Application

Hospital

Clinic

Other

Antithyroid Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithyroid Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithyroid Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithyroid Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antithyroid Preparations in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antithyroid Preparations manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antithyroid Preparations sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antithyroid Preparations Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Propylthiouracil Major Manufacturers Table 3. Methimazole Major Manufacturers Table 4. Global Antithyroid Preparations Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Other Major Manufacturers Table 8. Antithyroid Preparations Industry Trends Table 9. Antithyroid Preparations Industry Drivers Table 10. Antithyroid Preparations Industry Opportunities and Challenges Table 11. Antithyroid Preparations Industry Restraints Table 12. Global Antithyroid Preparations Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Antithyroid Preparations Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Antithyroid Preparations Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Antithyroid Preparations Revenue Market Share by Region (2021-2026) Table 16. Global Antithyroid Preparations Revenue Market Share by Region (2027-2032) Table 17. Global Antithyroid Preparations Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Antithyroid Preparations Sales by Region (2021-2026) & (K Units) Table 19. Global Antithyroid Preparations Sales by Region (2027-2032) & (K Units) Table 20. Global Antithyroid Preparations Sales Market Share by Region (2021-2026) Table 21. Global Antithyroid Preparations Sales Market Share by Region (2027-2032) Table 22. Global Antithyroid Preparations Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Antithyroid Preparations Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Antithyroid Preparations Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Antithyroid Preparations Sales Market Share by Manufacturers (2021-2026) Table 26. Global Antithyroid Preparations Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Antithyroid Preparations Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Antithyroid Preparations Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Antithyroid Preparations Manufacturers, Product Type & Application Table 30. Global Antithyroid Preparations Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Antithyroid Preparations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Antithyroid Preparations Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Antithyroid Preparations Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Antithyroid Preparations Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Antithyroid Preparations Revenue Market Share by Type (2021-2026) Table 37. Global Antithyroid Preparations Revenue Market Share by Type (2027-2032) Table 38. Global Antithyroid Preparations Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 40. Global Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 41. Global Antithyroid Preparations Sales Market Share by Type (2021-2026) Table 42. Global Antithyroid Preparations Sales Market Share by Type (2027-2032) Table 43. Global Antithyroid Preparations Price by Type (2021-2026) & (US$/Unit) Table 44. Global Antithyroid Preparations Price by Type (2027-2032) & (US$/Unit) Table 45. Global Antithyroid Preparations Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Antithyroid Preparations Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Antithyroid Preparations Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Antithyroid Preparations Revenue Market Share by Application (2021-2026) Table 49. Global Antithyroid Preparations Revenue Market Share by Application (2027-2032) Table 50. Global Antithyroid Preparations Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 52. Global Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 53. Global Antithyroid Preparations Sales Market Share by Application (2021-2026) Table 54. Global Antithyroid Preparations Sales Market Share by Application (2027-2032) Table 55. Global Antithyroid Preparations Price by Application (2021-2026) & (US$/Unit) Table 56. Global Antithyroid Preparations Price by Application (2027-2032) & (US$/Unit) Table 57. Taishan Xinning Pharmaceutical Co., Ltd. Company Information Table 58. Taishan Xinning Pharmaceutical Co., Ltd. Business Overview Table 59. Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 61. Taishan Xinning Pharmaceutical Co., Ltd. Recent Development Table 62. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Information Table 63. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview Table 64. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 66. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Development Table 67. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Company Information Table 68. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Business Overview Table 69. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 71. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Recent Development Table 72. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information Table 73. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview Table 74. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 76. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Development Table 77. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Company Information Table 78. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Business Overview Table 79. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 81. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Recent Development Table 82. Qilu Pharmaceutical Co., Ltd. Company Information Table 83. Qilu Pharmaceutical Co., Ltd. Business Overview Table 84. Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 86. Qilu Pharmaceutical Co., Ltd. Recent Development Table 87. Liaoning Kangbo Pharmaceutical Co., Ltd. Company Information Table 88. Liaoning Kangbo Pharmaceutical Co., Ltd. Business Overview Table 89. Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 91. Liaoning Kangbo Pharmaceutical Co., Ltd. Recent Development Table 92. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 93. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 94. Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 96. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Development Table 97. Jinghua Pharmaceutical Group Co., Ltd. Company Information Table 98. Jinghua Pharmaceutical Group Co., Ltd. Business Overview Table 99. Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 101. Jinghua Pharmaceutical Group Co., Ltd. Recent Development Table 102. Jinyao Pharmaceutical Co., Ltd. Company Information Table 103. Jinyao Pharmaceutical Co., Ltd. Business Overview Table 104. Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 106. Jinyao Pharmaceutical Co., Ltd. Recent Development Table 107. Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information Table 108. Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview Table 109. Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 111. Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Development Table 112. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 113. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 114. Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 116. Hunan Hansen Pharmaceutical Co., Ltd. Recent Development Table 117. Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information Table 118. Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview Table 119. Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 121. Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Development Table 122. Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information Table 123. Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview Table 124. Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 126. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Development Table 127. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information Table 128. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview Table 129. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 131. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Development Table 132. Guangdong South China Pharmaceutical Group Co., Ltd. Company Information Table 133. Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview Table 134. Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 136. Guangdong South China Pharmaceutical Group Co., Ltd. Recent Development Table 137. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 138. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 139. Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 141. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Development Table 142. Beijing Yongkang Pharmaceutical Co., Ltd. Company Information Table 143. Beijing Yongkang Pharmaceutical Co., Ltd. Business Overview Table 144. Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 146. Beijing Yongkang Pharmaceutical Co., Ltd. Recent Development Table 147. Beijing Jialin Pharmaceutical Co., Ltd. Company Information Table 148. Beijing Jialin Pharmaceutical Co., Ltd. Business Overview Table 149. Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 151. Beijing Jialin Pharmaceutical Co., Ltd. Recent Development Table 152. Beijing Beiwei Pharmaceutical Co., Ltd. Company Information Table 153. Beijing Beiwei Pharmaceutical Co., Ltd. Business Overview Table 154. Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 156. Beijing Beiwei Pharmaceutical Co., Ltd. Recent Development Table 157. Upsher-Smith Laboratories, LLC Company Information Table 158. Upsher-Smith Laboratories, LLC Business Overview Table 159. Upsher-Smith Laboratories, LLC Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Upsher-Smith Laboratories, LLC Antithyroid Preparations Product Portfolio Table 161. Upsher-Smith Laboratories, LLC Recent Development Table 162. Teva Company Information Table 163. Teva Business Overview Table 164. Teva Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Teva Antithyroid Preparations Product Portfolio Table 166. Teva Recent Development Table 167. Pfizer Company Information Table 168. Pfizer Business Overview Table 169. Pfizer Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Pfizer Antithyroid Preparations Product Portfolio Table 171. Pfizer Recent Development Table 172. Avet Pharmaceuticals Inc. Company Information Table 173. Avet Pharmaceuticals Inc. Business Overview Table 174. Avet Pharmaceuticals Inc. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Avet Pharmaceuticals Inc. Antithyroid Preparations Product Portfolio Table 176. Avet Pharmaceuticals Inc. Recent Development Table 177. North America Antithyroid Preparations Revenue by Type (2021-2026) & (US$ Million) Table 178. North America Antithyroid Preparations Revenue by Type (2027-2032) & (US$ Million) Table 179. North America Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 180. North America Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 181. North America Antithyroid Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 182. North America Antithyroid Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 183. North America Antithyroid Preparations Revenue by Application (2021-2026) & (US$ Million) Table 184. North America Antithyroid Preparations Revenue by Application (2027-2032) & (US$ Million) Table 185. North America Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 186. North America Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 187. North America Antithyroid Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 188. North America Antithyroid Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 189. North America Antithyroid Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. North America Antithyroid Preparations Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. North America Antithyroid Preparations Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. North America Antithyroid Preparations Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. North America Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 194. North America Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 195. North America Antithyroid Preparations Sales Price by Country (2021-2026) & (US$/Unit) Table 196. North America Antithyroid Preparations Sales Price by Country (2027-2032) & (US$/Unit) Table 197. United States Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 198. Canada Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 199. Mexico Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 200. Europe Antithyroid Preparations Revenue by Type (2021-2026) & (US$ Million) Table 201. Europe Antithyroid Preparations Revenue by Type (2027-2032) & (US$ Million) Table 202. Europe Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 203. Europe Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 204. Europe Antithyroid Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 205. Europe Antithyroid Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 206. Europe Antithyroid Preparations Revenue by Application (2021-2026) & (US$ Million) Table 207. Europe Antithyroid Preparations Revenue by Application (2027-2032) & (US$ Million) Table 208. Europe Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 209. Europe Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 210. Europe Antithyroid Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 211. Europe Antithyroid Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Europe Antithyroid Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Europe Antithyroid Preparations Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Europe Antithyroid Preparations Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Europe Antithyroid Preparations Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 216. Europe Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 217. Europe Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 218. Europe Antithyroid Preparations Sales Price by Country (2021-2026) & (US$/Unit) Table 219. Europe Antithyroid Preparations Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Germany Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 221. France Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 222. U.K. Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 223. Italy Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 224. Russia Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 225. Spain Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 226. Netherlands Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 227. Switzerland Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 228. Sweden Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 229. Poland Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 230. China Antithyroid Preparations Revenue by Type (2021-2026) & (US$ Million) Table 231. China Antithyroid Preparations Revenue by Type (2027-2032) & (US$ Million) Table 232. China Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 233. China Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 234. China Antithyroid Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 235. China Antithyroid Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 236. China Antithyroid Preparations Revenue by Application (2021-2026) & (US$ Million) Table 237. China Antithyroid Preparations Revenue by Application (2027-2032) & (US$ Million) Table 238. China Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 239. China Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 240. China Antithyroid Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 241. China Antithyroid Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 242. Asia Antithyroid Preparations Revenue by Type (2021-2026) & (US$ Million) Table 243. Asia Antithyroid Preparations Revenue by Type (2027-2032) & (US$ Million) Table 244. Asia Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 245. Asia Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 246. Asia Antithyroid Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 247. Asia Antithyroid Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 248. Asia Antithyroid Preparations Revenue by Application (2021-2026) & (US$ Million) Table 249. Asia Antithyroid Preparations Revenue by Application (2027-2032) & (US$ Million) Table 250. Asia Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 251. Asia Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 252. Asia Antithyroid Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 253. Asia Antithyroid Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 254. Asia Antithyroid Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 255. Asia Antithyroid Preparations Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 256. Asia Antithyroid Preparations Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 257. Asia Antithyroid Preparations Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 258. Asia Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 259. Asia Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 260. Asia Antithyroid Preparations Sales Price by Country (2021-2026) & (US$/Unit) Table 261. Asia Antithyroid Preparations Sales Price by Country (2027-2032) & (US$/Unit) Table 262. Japan Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 263. South Korea Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 264. India Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 265. Australia Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 266. Taiwan Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 267. Southeast Asia Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 268. SAMEA Antithyroid Preparations Revenue by Type (2021-2026) & (US$ Million) Table 269. SAMEA Antithyroid Preparations Revenue by Type (2027-2032) & (US$ Million) Table 270. SAMEA Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 271. SAMEA Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 272. SAMEA Antithyroid Preparations Sales Price by Type (2021-2026) & (US$/Unit) Table 273. SAMEA Antithyroid Preparations Sales Price by Type (2027-2032) & (US$/Unit) Table 274. SAMEA Antithyroid Preparations Revenue by Application (2021-2026) & (US$ Million) Table 275. SAMEA Antithyroid Preparations Revenue by Application (2027-2032) & (US$ Million) Table 276. SAMEA Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 277. SAMEA Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 278. SAMEA Antithyroid Preparations Sales Price by Application (2021-2026) & (US$/Unit) Table 279. SAMEA Antithyroid Preparations Sales Price by Application (2027-2032) & (US$/Unit) Table 280. SAMEA Antithyroid Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 281. SAMEA Antithyroid Preparations Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 282. SAMEA Antithyroid Preparations Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 283. SAMEA Antithyroid Preparations Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 284. SAMEA Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 285. SAMEA Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 286. SAMEA Antithyroid Preparations Sales Price by Country (2021-2026) & (US$/Unit) Table 287. SAMEA Antithyroid Preparations Sales Price by Country (2027-2032) & (US$/Unit) Table 288. Brazil Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 289. Argentina Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 290. Chile Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 291. Colombia Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 292. Peru Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 293. Saudi Arabia Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 294. Israel Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 295. UAE Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 296. Turkey Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 297. Iran Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 298. Egypt Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Table 299. Key Raw Materials Table 300. Raw Materials Key Suppliers Table 301. Antithyroid Preparations Distributors List Table 302. Antithyroid Preparations Customers List Table 303. Research Programs/Design for This Report Table 304. Authors List of This Report Table 305. Secondary Sources Table 306. Primary Sources List of Figures Figure 1. Antithyroid Preparations Image Figure 2. Global Antithyroid Preparations Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antithyroid Preparations Market Size Share 2021 VS 2025 VS 2032 Figure 4. Propylthiouracil Image Figure 5. Methimazole Image Figure 6. Global Antithyroid Preparations Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Antithyroid Preparations Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Other Image Figure 11. Global Antithyroid Preparations Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Antithyroid Preparations Revenue (2021-2032) & (US$ Million) Figure 13. Global Antithyroid Preparations Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Antithyroid Preparations Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Antithyroid Preparations Revenue Market Share by Region (2021-2032) Figure 16. Global Antithyroid Preparations Sales (2021-2032) & (K Units) Figure 17. Global Antithyroid Preparations Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Antithyroid Preparations Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Antithyroid Preparations Sales YoY (2021-2032) & (K Units) Figure 20. Europe Antithyroid Preparations Sales YoY (2021-2032) & (K Units) Figure 21. China Antithyroid Preparations Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Antithyroid Preparations Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Antithyroid Preparations Sales YoY (2021-2032) & (K Units) Figure 24. Global Antithyroid Preparations Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Antithyroid Preparations Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Antithyroid Preparations Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Antithyroid Preparations Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Antithyroid Preparations Revenue Market Share by Type (2021-2032) Figure 30. Global Antithyroid Preparations Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Antithyroid Preparations Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Antithyroid Preparations Sales Market Share by Type (2021-2032) Figure 33. Global Antithyroid Preparations Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Antithyroid Preparations Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Antithyroid Preparations Revenue Market Share by Application (2021-2032) Figure 36. Global Antithyroid Preparations Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Antithyroid Preparations Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Antithyroid Preparations Sales Market Share by Application (2021-2032) Figure 39. North America Antithyroid Preparations Revenue Share by Type (2021-2032) Figure 40. North America Antithyroid Preparations Sales Share by Type (2021-2032) Figure 41. North America Antithyroid Preparations Revenue Share by Application (2021-2032) Figure 42. North America Antithyroid Preparations Sales Share by Application (2021-2032) Figure 43. North America Antithyroid Preparations Revenue Share by Country (2021-2032) Figure 44. North America Antithyroid Preparations Sales Share by Country (2021-2032) Figure 45. Europe Antithyroid Preparations Revenue Share by Type (2021-2032) Figure 46. Europe Antithyroid Preparations Sales Share by Type (2021-2032) Figure 47. Europe Antithyroid Preparations Revenue Share by Application (2021-2032) Figure 48. Europe Antithyroid Preparations Sales Share by Application (2021-2032) Figure 49. Europe Antithyroid Preparations Revenue Share by Country (2021-2032) Figure 50. Europe Antithyroid Preparations Sales Share by Country (2021-2032) Figure 51. China Antithyroid Preparations Revenue Share by Type (2021-2032) Figure 52. China Antithyroid Preparations Sales Share by Type (2021-2032) Figure 53. China Antithyroid Preparations Re

Scope & coverage.

Types
  • Propylthiouracil
  • Methimazole
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Taishan Xinning Pharmaceutical Co., Ltd.
  • Shenzhen Zhonglian Pharmaceutical Co., Ltd.
  • Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
  • Shanghai Zhaohui Pharmaceutical Co., Ltd.
  • Sanmenxia Sinovi Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Liaoning Kangbo Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jinghua Pharmaceutical Group Co., Ltd.
  • Jinyao Pharmaceutical Co., Ltd.
  • Hunan Xiangzhong Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Guizhou Shengjitang Pharmaceutical Co., Ltd.
  • Guangzhou Kanghe Pharmaceutical Co., Ltd.
  • Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  • Guangdong South China Pharmaceutical Group Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Beijing Yongkang Pharmaceutical Co., Ltd.
  • Beijing Jialin Pharmaceutical Co., Ltd.
  • Beijing Beiwei Pharmaceutical Co., Ltd.
  • Upsher-Smith Laboratories, LLC
  • Teva
  • Pfizer
  • Avet Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antithyroid Preparations Market by Type
  3. 1.2.1 Global Antithyroid Preparations Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Propylthiouracil
  5. 1.2.3 Methimazole
  6. 1.3 Antithyroid Preparations Market by Application
  7. 1.3.1 Global Antithyroid Preparations Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Antithyroid Preparations Market Dynamics
  1. 2.1 Antithyroid Preparations Industry Trends
  2. 2.2 Antithyroid Preparations Industry Drivers
  3. 2.3 Antithyroid Preparations Industry Opportunities and Challenges
  4. 2.4 Antithyroid Preparations Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antithyroid Preparations Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antithyroid Preparations Revenue by Region
  3. 3.2.1 Global Antithyroid Preparations Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antithyroid Preparations Revenue by Region (2021-2026)
  5. 3.2.3 Global Antithyroid Preparations Revenue by Region (2027-2032)
  6. 3.2.4 Global Antithyroid Preparations Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antithyroid Preparations Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antithyroid Preparations Sales by Region
  9. 3.4.1 Global Antithyroid Preparations Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antithyroid Preparations Sales by Region (2021-2026)
  11. 3.4.3 Global Antithyroid Preparations Sales by Region (2027-2032)
  12. 3.4.4 Global Antithyroid Preparations Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antithyroid Preparations Revenue by Manufacturers
  2. 4.1.1 Global Antithyroid Preparations Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antithyroid Preparations Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antithyroid Preparations Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antithyroid Preparations Sales by Manufacturers
  6. 4.2.1 Global Antithyroid Preparations Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antithyroid Preparations Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antithyroid Preparations Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antithyroid Preparations Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antithyroid Preparations Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antithyroid Preparations Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antithyroid Preparations Manufacturers, Product Type & Application
  13. 4.7 Global Antithyroid Preparations Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antithyroid Preparations Market CR5 and HHI
  16. 4.8.2 2025 Antithyroid Preparations Tier 1, Tier 2, and Tier 3
5 Antithyroid Preparations Market by Type
  1. 5.1 Global Antithyroid Preparations Revenue by Type
  2. 5.1.1 Global Antithyroid Preparations Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antithyroid Preparations Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antithyroid Preparations Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antithyroid Preparations Sales by Type
  6. 5.2.1 Global Antithyroid Preparations Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antithyroid Preparations Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Antithyroid Preparations Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antithyroid Preparations Price by Type
6 Antithyroid Preparations Market by Application
  1. 6.1 Global Antithyroid Preparations Revenue by Application
  2. 6.1.1 Global Antithyroid Preparations Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antithyroid Preparations Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antithyroid Preparations Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antithyroid Preparations Sales by Application
  6. 6.2.1 Global Antithyroid Preparations Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antithyroid Preparations Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Antithyroid Preparations Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antithyroid Preparations Price by Application
7 Company Profiles
  1. 7.1 Taishan Xinning Pharmaceutical Co., Ltd.
  2. 7.1.1 Taishan Xinning Pharmaceutical Co., Ltd. Company Information
  3. 7.1.2 Taishan Xinning Pharmaceutical Co., Ltd. Business Overview
  4. 7.1.3 Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  6. 7.1.5 Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments
  7. 7.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd.
  8. 7.2.1 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  12. 7.2.5 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
  14. 7.3.1 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  18. 7.3.5 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Shanghai Zhaohui Pharmaceutical Co., Ltd.
  20. 7.4.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  24. 7.4.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Sanmenxia Sinovi Pharmaceutical Co., Ltd.
  26. 7.5.1 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  30. 7.5.5 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Qilu Pharmaceutical Co., Ltd.
  32. 7.6.1 Qilu Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  36. 7.6.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Liaoning Kangbo Pharmaceutical Co., Ltd.
  38. 7.7.1 Liaoning Kangbo Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Liaoning Kangbo Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  42. 7.7.5 Liaoning Kangbo Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Liaoning Dongyi Pharmaceutical Co., Ltd.
  44. 7.8.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  48. 7.8.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Jinghua Pharmaceutical Group Co., Ltd.
  50. 7.9.1 Jinghua Pharmaceutical Group Co., Ltd. Company Information
  51. 7.9.2 Jinghua Pharmaceutical Group Co., Ltd. Business Overview
  52. 7.9.3 Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  54. 7.9.5 Jinghua Pharmaceutical Group Co., Ltd. Recent Developments
  55. 7.10 Jinyao Pharmaceutical Co., Ltd.
  56. 7.10.1 Jinyao Pharmaceutical Co., Ltd. Company Information
  57. 7.10.2 Jinyao Pharmaceutical Co., Ltd. Business Overview
  58. 7.10.3 Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  60. 7.10.5 Jinyao Pharmaceutical Co., Ltd. Recent Developments
  61. 7.11 Hunan Xiangzhong Pharmaceutical Co., Ltd.
  62. 7.11.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  66. 7.11.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Hunan Hansen Pharmaceutical Co., Ltd.
  68. 7.12.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  72. 7.12.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Guizhou Shengjitang Pharmaceutical Co., Ltd.
  74. 7.13.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information
  75. 7.13.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview
  76. 7.13.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  78. 7.13.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments
  79. 7.14 Guangzhou Kanghe Pharmaceutical Co., Ltd.
  80. 7.14.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
  81. 7.14.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
  82. 7.14.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  84. 7.14.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
  85. 7.15 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  86. 7.15.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information
  87. 7.15.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
  88. 7.15.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  90. 7.15.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
  91. 7.16 Guangdong South China Pharmaceutical Group Co., Ltd.
  92. 7.16.1 Guangdong South China Pharmaceutical Group Co., Ltd. Company Information
  93. 7.16.2 Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview
  94. 7.16.3 Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  96. 7.16.5 Guangdong South China Pharmaceutical Group Co., Ltd. Recent Developments
  97. 7.17 Beijing Taiyang Pharmaceutical Co., Ltd.
  98. 7.17.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  99. 7.17.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  100. 7.17.3 Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  102. 7.17.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  103. 7.18 Beijing Yongkang Pharmaceutical Co., Ltd.
  104. 7.18.1 Beijing Yongkang Pharmaceutical Co., Ltd. Company Information
  105. 7.18.2 Beijing Yongkang Pharmaceutical Co., Ltd. Business Overview
  106. 7.18.3 Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  108. 7.18.5 Beijing Yongkang Pharmaceutical Co., Ltd. Recent Developments
  109. 7.19 Beijing Jialin Pharmaceutical Co., Ltd.
  110. 7.19.1 Beijing Jialin Pharmaceutical Co., Ltd. Company Information
  111. 7.19.2 Beijing Jialin Pharmaceutical Co., Ltd. Business Overview
  112. 7.19.3 Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  114. 7.19.5 Beijing Jialin Pharmaceutical Co., Ltd. Recent Developments
  115. 7.20 Beijing Beiwei Pharmaceutical Co., Ltd.
  116. 7.20.1 Beijing Beiwei Pharmaceutical Co., Ltd. Company Information
  117. 7.20.2 Beijing Beiwei Pharmaceutical Co., Ltd. Business Overview
  118. 7.20.3 Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  120. 7.20.5 Beijing Beiwei Pharmaceutical Co., Ltd. Recent Developments
  121. 7.21 Upsher-Smith Laboratories, LLC
  122. 7.21.1 Upsher-Smith Laboratories, LLC Company Information
  123. 7.21.2 Upsher-Smith Laboratories, LLC Business Overview
  124. 7.21.3 Upsher-Smith Laboratories, LLC Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Upsher-Smith Laboratories, LLC Antithyroid Preparations Product Portfolio
  126. 7.21.5 Upsher-Smith Laboratories, LLC Recent Developments
  127. 7.22 Teva
  128. 7.22.1 Teva Company Information
  129. 7.22.2 Teva Business Overview
  130. 7.22.3 Teva Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Teva Antithyroid Preparations Product Portfolio
  132. 7.22.5 Teva Recent Developments
  133. 7.23 Pfizer
  134. 7.23.1 Pfizer Company Information
  135. 7.23.2 Pfizer Business Overview
  136. 7.23.3 Pfizer Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Pfizer Antithyroid Preparations Product Portfolio
  138. 7.23.5 Pfizer Recent Developments
  139. 7.24 Avet Pharmaceuticals Inc.
  140. 7.24.1 Avet Pharmaceuticals Inc. Company Information
  141. 7.24.2 Avet Pharmaceuticals Inc. Business Overview
  142. 7.24.3 Avet Pharmaceuticals Inc. Antithyroid Preparations Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Avet Pharmaceuticals Inc. Antithyroid Preparations Product Portfolio
  144. 7.24.5 Avet Pharmaceuticals Inc. Recent Developments
8 North America
  1. 8.1 North America Antithyroid Preparations Market Size by Type
  2. 8.1.1 North America Antithyroid Preparations Revenue by Type (2021-2032)
  3. 8.1.2 North America Antithyroid Preparations Sales by Type (2021-2032)
  4. 8.1.3 North America Antithyroid Preparations Price by Type (2021-2032)
  5. 8.2 North America Antithyroid Preparations Market Size by Application
  6. 8.2.1 North America Antithyroid Preparations Revenue by Application (2021-2032)
  7. 8.2.2 North America Antithyroid Preparations Sales by Application (2021-2032)
  8. 8.2.3 North America Antithyroid Preparations Price by Application (2021-2032)
  9. 8.3 North America Antithyroid Preparations Market Size by Country
  10. 8.3.1 North America Antithyroid Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antithyroid Preparations Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antithyroid Preparations Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Antithyroid Preparations Market Size by Type
  2. 9.1.1 Europe Antithyroid Preparations Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antithyroid Preparations Sales by Type (2021-2032)
  4. 9.1.3 Europe Antithyroid Preparations Price by Type (2021-2032)
  5. 9.2 Europe Antithyroid Preparations Market Size by Application
  6. 9.2.1 Europe Antithyroid Preparations Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antithyroid Preparations Sales by Application (2021-2032)
  8. 9.2.3 Europe Antithyroid Preparations Price by Application (2021-2032)
  9. 9.3 Europe Antithyroid Preparations Market Size by Country
  10. 9.3.1 Europe Antithyroid Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antithyroid Preparations Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antithyroid Preparations Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Antithyroid Preparations Market Size by Type
  2. 10.1.1 China Antithyroid Preparations Revenue by Type (2021-2032)
  3. 10.1.2 China Antithyroid Preparations Sales by Type (2021-2032)
  4. 10.1.3 China Antithyroid Preparations Price by Type (2021-2032)
  5. 10.2 China Antithyroid Preparations Market Size by Application
  6. 10.2.1 China Antithyroid Preparations Revenue by Application (2021-2032)
  7. 10.2.2 China Antithyroid Preparations Sales by Application (2021-2032)
  8. 10.2.3 China Antithyroid Preparations Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antithyroid Preparations Market Size by Type
  2. 11.1.1 Asia Antithyroid Preparations Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antithyroid Preparations Sales by Type (2021-2032)
  4. 11.1.3 Asia Antithyroid Preparations Price by Type (2021-2032)
  5. 11.2 Asia Antithyroid Preparations Market Size by Application
  6. 11.2.1 Asia Antithyroid Preparations Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antithyroid Preparations Sales by Application (2021-2032)
  8. 11.2.3 Asia Antithyroid Preparations Price by Application (2021-2032)
  9. 11.3 Asia Antithyroid Preparations Market Size by Country
  10. 11.3.1 Asia Antithyroid Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antithyroid Preparations Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antithyroid Preparations Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antithyroid Preparations Market Size by Type
  2. 12.1.1 SAMEA Antithyroid Preparations Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antithyroid Preparations Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antithyroid Preparations Price by Type (2021-2032)
  5. 12.2 SAMEA Antithyroid Preparations Market Size by Application
  6. 12.2.1 SAMEA Antithyroid Preparations Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antithyroid Preparations Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antithyroid Preparations Price by Application (2021-2032)
  9. 12.3 SAMEA Antithyroid Preparations Market Size by Country
  10. 12.3.1 SAMEA Antithyroid Preparations Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antithyroid Preparations Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antithyroid Preparations Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antithyroid Preparations Value Chain Analysis
  2. 13.1.1 Antithyroid Preparations Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antithyroid Preparations Production Mode & Process
  6. 13.2 Antithyroid Preparations Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antithyroid Preparations Distributors
  9. 13.2.3 Antithyroid Preparations Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst